← All trials
NCT02878694
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2016
- Primary completion
- Apr 1, 2018
- Completion date
- Dec 1, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 10
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- University of Caen-NormandieLead sponsor
- University of RennesStudy chair
- Rouen Normandy UniversityStudy chair
- University of RennesCollaborator
- University of ParisCollaborator
- University of Picardie Jules VerneCollaborator
- University of Western BrittanyCollaborator
- University of LilleCollaborator
- University of ParisStudy chair
- University of Caen-NormandieStudy chair
- Rouen Normandy UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.